Back to Results
First PageMeta Content
Cardiac dysrhythmia / Stroke / Cardiac electrophysiology / Management of atrial fibrillation / Dabigatran / Apixaban / Atrial fibrillation / Rivaroxaban / Warfarin / Chemistry / Organic chemistry / Anticoagulants


Antithrombotic therapy QUM domain: Judicious selection 1.6 Percentage of patients with atrial fibrillation
Add to Reading List

Document Date: 2014-10-23 00:15:16

Open Document

File Size: 163,03 KB

Share Result on Facebook

City

Melbourne / Sydney / Stockholm / /

Company

NSW Therapeutic Advisory Group / Therapeutic Guidelines Limited / Bajorek BV / /

Country

Australia / /

Facility

National Institute of Clinical Studies / /

IndustryTerm

stroke prevention / data collection tool / /

MedicalCondition

D Diabetes / hypertension / nonvalvular atrial fibrillation / V Vascular disease / stroke / Cirrhosis / thromboembolism / S2 Stroke/Transient Ischaemic Attack/Thromboembolism / prior myocardial infarction / Renal Disease / coronary artery disease / peripheral artery disease / atrial fibrillation / C Congestive heart failure/left ventricular dysfunction / H Hypertension / Liver Disease / transient ischemic attacks / /

MedicalTreatment

pharmacotherapy / Dialysis / /

Organization

Australian Commission / European Society of Cardiology / /

Position

Governor / physician / Major / /

Product

Irbesartan / Denominator / If / vitamin K / Clopidogrel / The Medication / /

ProvinceOrState

Maryland / /

Technology

Dialysis / /

URL

www.cec.health.nsw.gov.au / /

SocialTag